Patients with Congenital Heart Disease have Inferior Intent-to-Treat Outcomes When Listed for Pediatric Heart Transplantation

While the impact of patient characteristics on waitlist and post-transplant mortality in pediatric heart transplantation has been widely studied, these metrics are limited in their ability to provide a complete picture for patients and their families. In contrast, less prevalent in the literature is an intent-to-treat analysis approach, which provides a single data point that encompasses both of these measures. This retrospective study examines pediatric patients listed for heart transplantation in the United Network for Organ Sharing (UNOS) database between 2016 and 2025, evaluating the impact of transplant indication on intent-to-treat outcomes following the implementation of the 2016 allocation policy, which prioritizes children with congenital heart disease (CHD) on inotropic support. Kaplan-Meier analysis by transplant indication was performed across all pediatric patients listed during the study period, followed by Cox regression analyses using clinical and demographic covariates. In this initial analysis, CHD patients had poorer intent-to-treat outcomes. Risk and protective factors in this particularly high-risk population were then identified using univariable Cox regression. Significant factors (p < 0.05) were entered into a multivariable Cox regression, which was used to generate a predictive score for one-year intent-to-treat mortality (c-statistic = 0.74). Risk factors significant in the multivariable analysis were age 0-1 years, geographic region, public (rather than private) insurance, need for life support and/or hemodialysis, and low serum albumin level. Following external validation and study of transplant timing on outcomes, these findings may serve as an additional tool to identify and prioritize high-risk patients and target modifiable risk factors.

Authors

Institutions

Publication Details

Journal
Pediatric Cardiology
Published
2026-11-18
DOI
https://doi.org/10.1007/s00246-026-04559-8
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patients with Congenital Heart Disease have Inferior Intent-to-Treat Outcomes When Listed for Pediatric Heart Transplantation

Abbas A. Rana, Noémie Gomes-Jourdan, Moomtahina Fatima, Chikaneme Orioha
1 links
Pediatric Cardiology
Transplantation: Methods and Outcomes
article

Patients with Congenital Heart Disease have Inferior Intent-to-Treat Outcomes When Listed for Pediatric Heart Transplantation

Abbas A. Rana, Noémie Gomes-Jourdan, Moomtahina Fatima, Chikaneme Orioha
article en

Abstract

While the impact of patient characteristics on waitlist and post-transplant mortality in pediatric heart transplantation has been widely studied, these metrics are limited in their ability to provide a complete picture for patients and their families. In contrast, less prevalent in the literature is an intent-to-treat analysis approach, which provides a single data point that encompasses both of these measures. This retrospective study examines pediatric patients listed for heart transplantation in the United Network for Organ Sharing (UNOS) database between 2016 and 2025, evaluating the impact of transplant indication on intent-to-treat outcomes following the implementation of the 2016 allocation policy, which prioritizes children with congenital heart disease (CHD) on inotropic support. Kaplan-Meier analysis by transplant indication was performed across all pediatric patients listed during the study period, followed by Cox regression analyses using clinical and demographic covariates. In this initial analysis, CHD patients had poorer intent-to-treat outcomes. Risk and protective factors in this particularly high-risk population were then identified using univariable Cox regression. Significant factors (p < 0.05) were entered into a multivariable Cox regression, which was used to generate a predictive score for one-year intent-to-treat mortality (c-statistic = 0.74). Risk factors significant in the multivariable analysis were age 0-1 years, geographic region, public (rather than private) insurance, need for life support and/or hemodialysis, and low serum albumin level. Following external validation and study of transplant timing on outcomes, these findings may serve as an additional tool to identify and prioritize high-risk patients and target modifiable risk factors.

Pediatric Cardiology
Baylor College of Medicine (US)
Good health and well-being
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon